Repairon Immuno GmbH is a young startup with the mission to develop novel cell therapies to treat most challenging diseases. To achieve this goal, we will take advantage of exclusively licensed induced Pluripotent Stem Cell (iPSC) line, which is the only iPSC line being currently validated in an European clinical trial. This cell line in combination with our proprietary, scalable, GMP-compliant differentiation platform as well as proprietary gene editing designs will enable us to generate never-done-before types of cell drug products.
Company Details
Repairon Immuno Questions
Repairon Immuno's LinkedIn profile is https://www.linkedin.com/company/repairon-immuno
Repairon Immuno has
4 employees.
View email and phone details for 4
employees at Repairon Immuno.
Repairon Immuno's industry is
Biotechnology Research
Repairon Immuno's top competitors are
Veraxa Biotech,
Evotec,
Iba Lifesciences,
Myriamed Gmbh,
Myriameat,
Repairon Gmbh,
Sartorius,
Nanotag Biotechnologies,
Universitätsmedizin Göttingen,
Life Science Factory.
Repairon Immuno's categories are Biotechnology Research
Repairon Immuno's founding year is 2019
